OpenAI launches Rosalind Biodefense and expands GPT-Rosalind access to government partners

According to the OpenAI Blog, OpenAI is launching Rosalind Biodefense, an initiative that provides trusted developers with sponsored access to GPT-Rosalind—the company’s frontier reasoning model for life sciences—to build operationalized biodefense and pandemic preparedness applications. The program focuses on areas such as epidemiological modeling, early detection, screening, and medical countermeasure development, with initial support for organizations including Fourth Eon Biosecurity.

OpenAI is also expanding trusted access to GPT-Rosalind for select U.S. government and allied partners with approved public health and biodefense missions. Named collaborators include Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the Coalition for Epidemic Preparedness Innovations (CEPI), which intend to use the model for biopreparedness research, protein engineering, and accelerated vaccine development.

The company described these efforts as part of a broader strategy to ensure frontier AI advantages societal defenders, building on existing safety work under its Preparedness Framework, bio-specific capability assessments, and partnerships with institutions such as the UK AI Security Institute and Los Alamos National Laboratory.